View in EDS

Could oritavancin be a promising alternative treatment for staphylococcal bone and joint infections? Insights from the determination of oritavancin minimum inhibitory concentrations in a collection of clinical isolates from the French National reference centre for staphylococci

Saved in:
Bibliographic Details
Title: Could oritavancin be a promising alternative treatment for staphylococcal bone and joint infections? Insights from the determination of oritavancin minimum inhibitory concentrations in a collection of clinical isolates from the French National reference centre for staphylococci
Authors: Berrada, M.1 (AUTHOR) marion.berrada@chu-lyon.fr, Kolenda, C.1,2 (AUTHOR), Tristan, A.1 (AUTHOR), Laurent, F.1,2 (AUTHOR), Dupieux, C.1,2 (AUTHOR)
Source: European Journal of Clinical Microbiology & Infectious Diseases. May2026, Vol. 45 Issue 5, p1477-1481. 5p.
Database: Environment Complete
Description
ISSN:09349723
DOI:10.1007/s10096-025-05383-3